BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25824658)

  • 1. 'Conditioning the heart' - lessons we have learned from the past and future perspectives for new and old conditioning 'drugs'.
    Weber NC
    Br J Pharmacol; 2015 Apr; 172(8):1909-12. PubMed ID: 25824658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial ischaemia reperfusion injury and cardioprotection in the presence of sensory neuropathy: Therapeutic options.
    Bencsik P; Gömöri K; Szabados T; Sántha P; Helyes Z; Jancsó G; Ferdinandy P; Görbe A
    Br J Pharmacol; 2020 Dec; 177(23):5336-5356. PubMed ID: 32059259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac conditioning: a review of evolving strategies to reduce ischaemia-reperfusion injury.
    Kharbanda RK
    Heart; 2010 Aug; 96(15):1179-86. PubMed ID: 20558460
    [No Abstract]   [Full Text] [Related]  

  • 4. ERICCA and RIPHeart: two nails in the coffin for cardioprotection by remote ischemic conditioning? Probably not!
    Heusch G; Gersh BJ
    Eur Heart J; 2016 Jan; 37(2):200-2. PubMed ID: 26508160
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiac pre- and post-conditioning: implications in anesthesia?
    Pesonen E
    Acta Anaesthesiol Scand; 2010 Aug; 54(7):793-4. PubMed ID: 20649515
    [No Abstract]   [Full Text] [Related]  

  • 6. Ischaemic conditioning for myocardial salvage after AMI.
    Ibanez B; Fuster V
    Lancet; 2010 May; 375(9727):1691; author reply 1692. PubMed ID: 20472164
    [No Abstract]   [Full Text] [Related]  

  • 7. Myocardial protection from ischemia-reperfusion injury post coronary revascularization.
    Binder A; Ali A; Chawla R; Aziz HA; Abbate A; Jovin IS
    Expert Rev Cardiovasc Ther; 2015; 13(9):1045-57. PubMed ID: 26202544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioprotection: chances and challenges of its translation to the clinic.
    Heusch G
    Lancet; 2013 Jan; 381(9861):166-75. PubMed ID: 23095318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efforts to reduce myocardial infarct size--the next step.
    Braunwald E
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):349-53. PubMed ID: 21821538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is Wrong With Cardiac Conditioning? We May be Shooting at Moving Targets.
    Iliodromitis EK; Cohen MV; Dagres N; Andreadou I; Kremastinos DT; Downey JM
    J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):357-69. PubMed ID: 25627214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protecting the heart from ischemia: an update on ischemic and pharmacologic conditioning.
    Gerczuk PZ; Kloner RA
    Hosp Pract (1995); 2011 Aug; 39(3):35-43. PubMed ID: 21881390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remote conditioning the heart overview: translatability and mechanism.
    Schmidt MR; Redington A; Bøtker HE
    Br J Pharmacol; 2015 Apr; 172(8):1947-60. PubMed ID: 25219984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial mechanisms are at the 'heart' of novel ischemia-reperfusion therapies.
    Crouser ED; Parinandi N
    Crit Care Med; 2011 Mar; 39(3):593-5. PubMed ID: 21330862
    [No Abstract]   [Full Text] [Related]  

  • 14. Is it time to translate ischemic preconditioning's mechanism of cardioprotection into clinical practice?
    Cohen MV; Downey JM
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):273-80. PubMed ID: 21821528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is oxytocin a therapeutic factor for ischemic heart disease?
    Alizadeh AM; Mirzabeglo P
    Peptides; 2013 Jul; 45():66-72. PubMed ID: 23659864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PI3K/Akt signaling pathway involved in cardioprotection of preconditioning with high mobility group box 1 protein during myocardial ischemia and reperfusion.
    Hu X; Xu C; Zhou X; Cui B; Lu Z; Jiang H
    Int J Cardiol; 2011 Jul; 150(2):222-3. PubMed ID: 21632128
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperlipidaemia and cardioprotection: Animal models for translational studies.
    Andreadou I; Schulz R; Badimon L; Adameová A; Kleinbongard P; Lecour S; Nikolaou PE; Falcão-Pires I; Vilahur G; Woudberg N; Heusch G; Ferdinandy P
    Br J Pharmacol; 2020 Dec; 177(23):5287-5311. PubMed ID: 31769007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning.
    Heusch G
    Circ Res; 2015 Feb; 116(4):674-99. PubMed ID: 25677517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ageing, sex, and cardioprotection.
    Ruiz-Meana M; Boengler K; Garcia-Dorado D; Hausenloy DJ; Kaambre T; Kararigas G; Perrino C; Schulz R; Ytrehus K
    Br J Pharmacol; 2020 Dec; 177(23):5270-5286. PubMed ID: 31863453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remote cardiac ischemic conditioning: underlying mechanisms and clinical applications.
    Gaspar A; Leite-Moreira AF
    Rev Port Cir Cardiotorac Vasc; 2012; 19(4):183-90. PubMed ID: 24490195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.